Sounds of Support: COTA & Friends Unite for Young Adults with Cancer
Cancer affects everyone, including adolescents and young adults who are at increasing risk of developing certain types of disease. It’s a particularly challenging time of life to receive a cancer diagnosis. Many cancers in younger patients can be aggressive, and treatment can be complicated, expensive, painful, and isolating for young people who should be focused […]
Extending COTA’s global reach with RWD in oncology research
Cancer is a disease that respects no borders: it affects everyone around the world, no matter where they live. The universal nature of cancer makes it even more important for international partners to collaborate on research and share learnings to improve outcomes everywhere, from the Americas to Europe, Africa to Asia, and beyond. This year, […]
3 key takeaways from ASCO 2025: Staying nimble in a changing environment
3 key takeaways from ASCO 2025: Staying nimble in a changing environment The annual meeting of the American Society of Clinical Oncology (ASCO) is a chance for oncology professionals, patient advocates, data experts, and industry representatives to come together and share the latest research in cancer care. This year, thousands of attendees descended on Chicago […]
How real-world ovarian cancer data will improve outcomes for women
As we recognize Women’s Health Month and approach Mother’s Day, this is a chance to lead differently. We can ask better questions. We can design smarter trials. We can act on data that reflects real life, not just ideal scenarios. One in eight women will develop breast cancer during their lifetime. This year alone in […]
How real-world data can tell the story of breast, ovarian and uterine cancers at a pivotal moment in women’s health
Nearly 4 million women worldwide are diagnosed with breast or gynecological cancers each year. Yet too many factors around these diseases are still poorly understood, including why there are so many disparities and variances in treatment and outcomes. Clinical trials have been helpful in illuminating some of these issues. And early approaches to leveraging real-world […]
Expanding insights into cancer with real-world data on solid tumors
Cancer comes in many forms, including hematologic malignancies that originate in blood-forming tissues or in the cells of the immune system, and solid tumors that form as abnormal masses of tissue and are named for the type of cells and classified by the organ or biologic structure from which they originate. Hematologic cancers, such as […]
Sustainability spotlight: How COTA is approaching corporate ecological responsibility
Since the turn of the century, there’s been a growing recognition that the health of our friends, families, & communities is intimately tied to the health of our physical environment. Safe water, clean air, & a diverse, balanced ecosystem are essential conditions for life to thrive & innovation to flourish.As a company focused on healthcare […]
COTA and PHI, a subsidiary of Texas Oncology, partner to deliver precision medicine for cancer patients
For over a decade, COTA has been tackling the most complicated cancer data to produce real-world data that can power research that will improve care and expand treatment options for patients. And now, with the integration of AI into our data curation process, we have the potential to do data-assisted clinical research with more speed […]
Research from COTA and leading global cancer center demonstrate how Real-World Data can fill cancer care gaps for older patients
COTA and Memorial Sloan Kettering Cancer Center will present the findings from their research collaboration on Diffuse Large B-Cell Lymphoma (DLBCL) studies in older patients at the upcoming American Society of Hematology Annual Meeting (ASH) next month.
The power of platforms: How data companies can accelerate the use of quality RWD for clinical research
Not all data platforms are created equal, and not all data companies are employing the same techniques to produce reliable and consistent results, notes a recent white paper from the Clinical Research Data Sharing Alliance (CRDSA).
